Metrovacesa SA
MAD:MVC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.48
9.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Metrovacesa SA
Total Equity
Metrovacesa SA
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Metrovacesa SA
MAD:MVC
|
Total Equity
€1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
||
Aedas Homes SA
MAD:AEDAS
|
Total Equity
€895.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
||
Renta Corporacion Real Estate SA
MAD:REN
|
Total Equity
€59.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
31%
|
Metrovacesa SA
Glance View
Founded in 1918, Metrovacesa SA has traversed the landscape of Spain's real estate industry to become a pivotal player in the sector. Emerging from a lineage deeply rooted in property and construction, Metrovacesa has evolved through the decades by strategically pivoting towards prevailing market demands. The company has skillfully navigated the Spanish real estate booms and crises, reflecting both resilience and adaptability. Traditionally, Metrovacesa's core business focused on developing residential properties. However, the company expanded its portfolio to include the development and management of commercial real estate, capturing the growing demand for business spaces and retail complexes in urban centers. This dual approach has allowed it to diversify its revenue streams and mitigate risks inherent in the real estate market. Metrovacesa's business model is anchored in the acquisition of strategic land parcels, where it leverages its development expertise to create highly attractive residential and commercial properties. Revenue generation flows primarily from the sale of these developed properties and the strategic leasing of commercial spaces. By investing in land assets and utilizing detailed market analysis to predict urban growth, Metrovacesa ensures not only the profitability of its developments but also the sustainable expansion of its offerings. The company's focus extends beyond immediate sales, incorporating long-term value creation through customer satisfaction and community impact. Through strategic alliances and a strong commitment to quality and innovation, Metrovacesa adeptly positions itself at the forefront of Spain's real estate development, continuously shaping the urban landscape with an eye for both profit and sustainability.
See Also
What is Metrovacesa SA's Total Equity?
Total Equity
1.6B
EUR
Based on the financial report for Jun 30, 2024, Metrovacesa SA's Total Equity amounts to 1.6B EUR.
What is Metrovacesa SA's Total Equity growth rate?
Total Equity CAGR 5Y
-7%
Over the last year, the Total Equity growth was -5%. The average annual Total Equity growth rates for Metrovacesa SA have been -8% over the past three years , -7% over the past five years .